This paper is only available as a PDF. To read, Please Download here.
Abstract
The three commonly used techniques for prenatal diagnosis provide choices for many
women. Changes in genetic diagnostic techniques now mean that these choices become
even wider. It is imperative that in counselling women for prenatal diagnosis a full
understanding of the available techniques, advantages and disadvantages are understood.
Occasionally the need for a specific sample will dictate which procedure is undertaken,
but for simple karyotype, the most common indication, choices can usually be offered.
Units providing prenatal diagnosis must audit their outcomes, and provide this data
to women in order that informed choice may be given. Because the median time to fetal
loss is longer than had previously been recognized, women must be counselled that
miscarriage can be a late event, particularly after amniocentesis.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Obstetrics, Gynaecology and Reproductive MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
REFERENCES
- Absence of need for amniocentesis in patients with elevated levels of maternal serum alphafetoprotein and normal ultrasound examinations.N Eng J Med. 1990; 323: 557-561
- Defining the role of fluorescence in situ hybridisation on uncultured amniocytes for prental diagnosis of aneuploidies.Am J Obstet Gynecol. 1997; 176: 769-776
- Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridisation: clinical experience with 4,500 specimens.Am J Hum Genet. 1993; 52: 854-865
- Rapid and simple prenatal DNA diagnosis of Down’s syndrome.Lancet. 1998; 352: 9-12
- Factors associated with maternal cell contamination in amniocentesis samples as evaluated by fluorescent in situ hybridization.Obstetrics & Gynecology. 1998; 92: 551-556
- Lancet. 1998; 351: 242-247
- Procedure related fetal losses in transplacental versus nontransplacental genetic amniocentesis.Am J Obstet Gynecol. 1995; 172: 868-872
- JAMA. 1976; 236: 1471-1476
- Randomised controlled trial of genetic amniocentesis in 4606 low risk women.Lancet. 1986; i: 1287-1293
- Experimental production of pulmonary hypoplasia following amniocentesis and oligohydramnios.Early Human Development. 1983; 8: 343-350
- Midtrimester amniocentesis. Influence of operator caseload on sampling efficiency.J Reprod Med. 1998; 43(3): 191-195
- European collaborative study on prenatal diagnosis: mosaicism, pseudomosaicism and single abnormal cells in amniotic fluid cultures.Prenatal Diagnosis. 1984; 4: 145-162
- Failure of amniotic fluid cell growth: is it related to fetal aneuploidy?.Lancet. 1995; 345: 96-97
- Chinese Medical Journal. 1975; 1: 117
- Chorion biopsy in early pregnancy: a method of early prenatal diagnosis for inherited disorders.Prenatal Diagnosis. 1982; 2: 39-45
- Transabdominal fine needle biopsy from chorionic villi in the first trimester.Prenatal Diagnosis. 1984; 4: 163-169
- Chorion villus sampling and limb deficiency-cause or coincidence?.Prenatal Diagnosis. 1997; 17: 1313-1330
- Chorionic villus sampling.Obstetrics and Gynecology Clinics of North America. 1997; 24: 83-110
- Benefits of placental biopsies for rapid karyotyping in the second and third trimesters (late chorionic villus sampling) in high-risk pregnancies.Am J Obstet Gynecol. 1990; : 162
- Randomized clinical trial of transabdominal versus transcervical chorionic villus sampling methods.Prenatal Diagnosis. 1991; 11: 285-293
- A randomised comparison of transcervical and transabdominal chorionic villus sampling.N Engl J Med. 1992; : 327
- Lancet. 1989; 1: 1-6
- Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling.Lancet. 1992; 340: 1237-1244
- Amniotic bands and malformation in child born after pregnancy screened by chorion villus biopsy.Lancet. 1986; 2: 756-757
- Fetal limb constriction: a possible complication of CVS.Prenat Diagn. 1989; 9: 67-71
- Severe limb abnormalities after chorion villus sampling at 56–66 days’ gestation.Lancet. 1991; 337: 762-763
- Analysis of limb reduction defects in babies exposed to chorionic villus sampling.Lancet. 1994; 343: 1069-1071
- Chorionic villus sampling: Experience of the first 1000 cases.Am J Obstet Gynecol. 1986; 154: 1249-1252
- Efficient Direct Chromosome Analyses and Enzyme Determinations from Chorionic Villi Samples in the First Trimester of Pregnancy.Human Genetics. 1983; 63: 349-357
- Transabdominal chorionic villus sampling: Method, safety and accuracy.Danish Medical Bulletin. 1998; 45: 402-411
- Accuracy of cytogenetic findings on chorionic villus sampling (CVS) – diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986–1992.Prenat Diagn. 1997; 17: 801-820
- Confined placental mosaicism and intrauterine fetal growth.Arch Dis Child Fetal Neonatal ed. 1998; 79: F223-F226
- The risks of early cordocentesis (12–21 weeks): analysis of 500 cases.Prenatal Diagnosis. 1990; 10: 425-428
- Fetal bradycardia following cordocentesis.Prenatal Diagnosis. 1997; 17: 919-923
- Fetal blood sampling during pregnancy with a needle guided by ultrasound: a study of 606 consecutive cases.Am J Obstet Gynecol. 1985; 153: 655-659
Article info
Identification
Copyright
© 1999 Published by Elsevier Inc. All rights reserved.